Generalized rash, intense itching, and mild fever after two days of antibiotic treatment for recurrent pyelonephritis
Abstract
A 26-year-old woman with no significant comorbidities, came to the emergency room with fever, low back pain, and dysuria of two days' duration. The patient has a history of recurrent pyelonephritis with several episodes in the last three years, successfully treated with various antibiotics. On this occasion, acute pyelonephritis was diagnosed by urine analysis that showed pyuria and bacteriuria. Empirical treatment was started with trimethoprim-sulfamethoxazole (TMP-SMX) due to its efficacy and its adequate spectrum of activity. However, two days after starting treatment, the patient developed an acute adverse reaction, characterized by diffuse maculopapular skin rash, intense itching, and mild fever (37.6 ° C). She has no history of allergies to medications, nor a family history of severe allergic reactions. She lives alone and has no children. She does not report having consulted a doctor in the last three years. She does not take other medications or have a history of recent viral infections. The patient reports not having had similar reactions in the past, including during previous episodes of pyelonephritis treated with other antibiotics. antibiotics.
Downloads
References
2. Wei-I Lee, Lydia Lam, Stephen Bacchi, Melinda Jiang, Joshua M. Inglis, William Smith, Pravin Hissaria, Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label,World Allergy Organization Journal, 2024, Volume 17, Issue 1,100856, ISSN 1939-4551, https://doi.org/10.1016/j.waojou.2023.100856.
3. Jakwerth CA, Ordovas-Montanes J, Blank S, Schmidt-Weber CB, Zissler UM. Role of Respiratory Epithelial Cells in Allergic Diseases. Cells. 2022 Apr 20;11(9):1387. doi: 10.3390/cells11091387.
4. Kemnic TR, Coleman M. Trimetoprima Sulfametoxazol. [Actualizado el 28 de noviembre de 2022]. En: StatPearls [Internet]. Isla del Tesoro (FL): StatPearls Publishing; 2024 enero-. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK513232/
5. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2020;20(4):333-341. DOI: 10.1097/ACI.0000000000000657
6. Jarkvist J, Gülen T. Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients. Diagnostics (Basel). 2023 Jun 30;13(13):2241. doi: 10.3390/diagnostics13132241. PMID: 37443635; PMCID: PMC10340660.2020;8(2):1105-1112.e1. DOI: 10.1016/j.jaip.2019.08.033
7. Sáenz de Santa María R, Bogas G, Labella M, Ariza A, Salas M, Doña I, Torres MJ. Approach for delabeling beta-lactam allergy in children. Front Allergy. 2023 Nov 15;4:1298335. doi: 10.3389/falgy.2023.1298335. Erratum in: Front Allergy. 2024 Jan 12;4:1361973. doi: 10.3389/falgy.2023.1361973.
8. Peter JG, Lehloenya RJ, Dlamini S, et al. Delayed hypersensitivity reactions to co-trimoxazole in HIV-infected patients: Clinical characterization and T cell mechanisms. Clin Exp Allergy. 2021;51(4):540-552. DOI: 10.1111/cea.13843
9. Benesch HA, Atluri VL, Healy B, Rampur L. Outcome of trimethoprim-sulfamethoxazole challenge in previously reported patients with sulfa antibiotic allergy. Ann Allergy Asthma Immunol. 2021 Jul;127(1):140-142. doi: 10.1016/j.anai.2021.04.001.
10. Ziemann M, Toda M, Takahagi S, et al. Drug hypersensitivity reactions: an update on clinical practice. J Allergy Clin Immunol. 2020;146(3):525-536. DOI: 10.1016/j.jaci.2020.06.017
Copyright (c) 2024 Rural Family Practice
This work is licensed under a Creative Commons Attribution 4.0 International License.